PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Aaron S. Kesselheim (akesselheim@bwh.harvard.edu) is a professor of medicine and the director of the Program on Regulation, Therapeutics, and Law in the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\'s Hospital and Harvard Medical School, in Boston, Massachusetts.\', \'Jonathan J. Darrow is an assistant professor of medicine in the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\'s Hospital and Harvard Medical School.\', \'Martin Kulldorff is a professor of medicine in the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\'s Hospital and Harvard Medical School.\', \'Beatrice L. Brown is a research assistant in the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\'s Hospital and Harvard Medical School.\', \'Mayookha Mitra-Majumdar is a research scientist in the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\'s Hospital and Harvard Medical School.\', \'ChangWon C. Lee is a research assistant in the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\'s Hospital and Harvard Medical School.\', \'Osman Moneer is a medical student at the Yale School of Medicine, in New Haven, Connecticut.\', \'Jerry Avorn is a professor of medicine in the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\'s Hospital and Harvard Medical School.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1377/hlthaff.2020.01620
?:doi
?:hasPublicationType
?:journal
  • Health affairs (Project Hope)
is ?:pmid of
?:pmid
?:pmid
  • 33211535
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33211535>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33211535>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all